Exact Mass: 600.3179

Exact Mass Matches: 600.3179

Found 55 metabolites which its exact mass value is equals to given mass value 600.3179, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

LysoPI(0:0/18:0)

[(2R)-3-hydroxy-2-(octadecanoyloxy)propoxy]({[(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy})phosphinic acid

C27H53O12P (600.3274)

LysoPI(0:0/18:0) is a lysophosphatidylinositol. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic. However, it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Lysophosphatidylinositols can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. LysoPI(0:0/18:0), in particular, consists of one chain of stearic acid at the C-2 position.

LysoPI(18:0/0:0)

[(2R)-2-hydroxy-3-(octadecanoyloxy)propoxy]({[(1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy})phosphinic acid

C27H53O12P (600.3274)

LysoPI(18:0/0:0) is a lysophosphatidylinositol. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic. However, it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Lysophosphatidylinositols can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. LysoPI(18:0/0:0), in particular, consists of one chain of stearic acid at the C-1 position.

4alpha-acetyl-2beta-angeloyl-5alpha,8-diisobutyryl-1beta,3alpha,10,11-tetrahydroxybisabolene

C30H48O12 (600.3146)

4alpha-acetyl-2beta-angeloyl-5alpha,10-diisobutyryl-1beta,3alpha,8,11-tetrahydroxybisabolene

C30H48O12 (600.3146)

6-acetoxytropan-3-yl tropan-3-yl truxillate

C36H44N2O6 (600.3199)

Phosphatidylinositol lyso 18:0

C27H53O12P (600.3274)

[2-hydroxy-3-[hydroxy-[2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxypropyl] octadecanoate

C27H53O12P (600.3274)

Lys Lys Tyr Tyr

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanamido]-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanoic acid

C30H44N6O7 (600.3271)

Lys Tyr Lys Tyr

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(4-hydroxyphenyl)propanamido]hexanamido]-3-(4-hydroxyphenyl)propanoic acid

C30H44N6O7 (600.3271)

Lys Tyr Tyr Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanamido]hexanoic acid

C30H44N6O7 (600.3271)

Tyr Lys Lys Tyr

(2S)-2-[(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]hexanamido]hexanamido]-3-(4-hydroxyphenyl)propanoic acid

C30H44N6O7 (600.3271)

Tyr Lys Tyr Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]hexanamido]-3-(4-hydroxyphenyl)propanamido]hexanoic acid

C30H44N6O7 (600.3271)

Tyr Tyr Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanamido]hexanamido]hexanoic acid

C30H44N6O7 (600.3271)

PI(18:0/0:0)

1-octadecanoyl-sn-glycero-3-phospho-(1-myo-inositol)

C27H53O12P (600.3274)

LPI 18:0

1-octadecanoyl-sn-glycero-3-phospho-(1-myo-inositol)

C27H53O12P (600.3274)

Glc-GP 18:0

1-octadecanoyl-sn-glycero-3-phospho-(1-beta-D-glucose)

C27H53O12P (600.3274)

1-stearoyl-sn-glycero-3-phospho-1D-myo-inositol

C27H53O12P (600.3274)

A 1-acyl-sn-glycero-3-phospho-1D-myo-inositol in which the 1-acyl group is specified as stearoyl.

2-Stearoylglycerophosphoinositol

C27H53O12P (600.3274)

(2R)-2-hydroxy-3-[(hydroxy{[(1S,2R,3S,4S,5S,6S)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl)oxy]propyl stearate

C27H53O12P (600.3274)

[2-Hydroxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropyl] octadecanoate

C27H53O12P (600.3274)

Smgdg O-9:0_9:0

C27H52O12S (600.3179)

Smgdg O-12:0_6:0

C27H52O12S (600.3179)

Smgdg O-10:0_8:0

C27H52O12S (600.3179)

Smgdg O-13:0_5:0

C27H52O12S (600.3179)

Smgdg O-8:0_10:0

C27H52O12S (600.3179)

Smgdg O-15:0_3:0

C27H52O12S (600.3179)

Smgdg O-14:0_4:0

C27H52O12S (600.3179)

Smgdg O-16:0_2:0

C27H52O12S (600.3179)

Smgdg O-11:0_7:0

C27H52O12S (600.3179)

1-octadecanoyl-sn-glycero-3-phospho-(1-myo-inositol)

C27H53O12P (600.3274)

DGGA 21:3;O

C30H48O12 (600.3146)

LPI 0:0/18:0

C27H53O12P (600.3274)

LPI 18:0/0:0

C27H53O12P (600.3274)

6-O-(1-O-Stearoyl-sn-glycero-3-phosphono)-1D-myo-inositol

C27H53O12P (600.3274)

PI O-14:0/4:0

C27H53O12P (600.3274)

PI O-16:0/2:0

C27H53O12P (600.3274)

PI O-18:0

C27H53O12P (600.3274)

ST 24:1;O6;GlcA

C30H48O12 (600.3146)

ST 24:2;O7;Hex

C30H48O12 (600.3146)

(6s,9s,12s,15s,20as)-9-benzyl-15-[(2s)-butan-2-yl]-1,4,7,10,13-pentahydroxy-12-(hydroxymethyl)-6-isopropyl-3h,6h,9h,12h,15h,18h,19h,20h,20ah-pyrrolo[1,2-a]1,4,7,10,13,16-hexaazacyclooctadecan-16-one

C30H44N6O7 (600.3271)

7-{4-[({9,9-dimethyl-3-oxa-9-azatricyclo[3.3.1.0²,⁴]nonan-9-ium-7-yl}oxy)carbonyl]-1-phenyl-3,4-dihydro-2h-naphthalene-1-carbonyloxy}-9,9-dimethyl-3-oxa-9-azatricyclo[3.3.1.0²,⁴]nonan-9-ium

[C36H44N2O6]2+ (600.3199)

1-(1r,3r,5s,6r)-6-(acetyloxy)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-(1r,5s)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3,4-diphenylcyclobutane-1,2-dicarboxylate

C36H44N2O6 (600.3199)

(1s,2r,3s,4s,5s,6s)-3-(acetyloxy)-5-[(3r,5s)-3,6-dihydroxy-6-methyl-5-[(2-methylpropanoyl)oxy]hept-1-en-2-yl]-2,6-dihydroxy-2-methyl-4-[(2-methylpropanoyl)oxy]cyclohexyl (2z)-2-methylbut-2-enoate

C30H48O12 (600.3146)

(1s,2r,3s,4s,5s,6s)-3-(acetyloxy)-5-[(3s,5s)-5,6-dihydroxy-6-methyl-3-[(2-methylpropanoyl)oxy]hept-1-en-2-yl]-2,6-dihydroxy-2-methyl-4-[(2-methylpropanoyl)oxy]cyclohexyl (2z)-2-methylbut-2-enoate

C30H48O12 (600.3146)

(1r,2r,5s,6r,10r,11s,12r,15r,16r,18s,19r)-16-(acetyloxy)-6-(furan-3-yl)-11-hydroxy-1,5,10,15-tetramethyl-13-oxapentacyclo[10.6.1.0²,¹⁰.0⁵,⁹.0¹⁵,¹⁹]nonadec-8-en-18-yl (2e)-3-phenylprop-2-enoate

(1r,2r,5s,6r,10r,11s,12r,15r,16r,18s,19r)-16-(acetyloxy)-6-(furan-3-yl)-11-hydroxy-1,5,10,15-tetramethyl-13-oxapentacyclo[10.6.1.0²,¹⁰.0⁵,⁹.0¹⁵,¹⁹]nonadec-8-en-18-yl (2e)-3-phenylprop-2-enoate

C37H44O7 (600.3087)

1-(1r,3r,5s,6r)-6-(acetyloxy)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-(1r,3s,5s)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl (1r,2s,3s,4s)-3,4-diphenylcyclobutane-1,2-dicarboxylate

C36H44N2O6 (600.3199)

3-(acetyloxy)-5-{3,6-dihydroxy-6-methyl-5-[(2-methylpropanoyl)oxy]hept-1-en-2-yl}-2,6-dihydroxy-2-methyl-4-[(2-methylpropanoyl)oxy]cyclohexyl 2-methylbut-2-enoate

C30H48O12 (600.3146)

1-(1r,5s)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-(1r,3r,5s,6r)-6-(propanoyloxy)-8-azabicyclo[3.2.1]octan-3-yl 3,4-diphenylcyclobutane-1,2-dicarboxylate

C36H44N2O6 (600.3199)

1-(1r,3s,5s)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-(1r,3r,5s,6r)-6-(propanoyloxy)-8-azabicyclo[3.2.1]octan-3-yl (1r,2r,3s,4s)-3,4-diphenylcyclobutane-1,2-dicarboxylate

C36H44N2O6 (600.3199)

3-(acetyloxy)-5-{5,6-dihydroxy-6-methyl-3-[(2-methylpropanoyl)oxy]hept-1-en-2-yl}-2,6-dihydroxy-2-methyl-4-[(2-methylpropanoyl)oxy]cyclohexyl 2-methylbut-2-enoate

C30H48O12 (600.3146)

16-(acetyloxy)-6-(furan-3-yl)-11-hydroxy-1,5,10,15-tetramethyl-13-oxapentacyclo[10.6.1.0²,¹⁰.0⁵,⁹.0¹⁵,¹⁹]nonadec-8-en-18-yl 3-phenylprop-2-enoate

C37H44O7 (600.3087)